Andrew Knight

Andrew Knight is a highly experienced professional in the field of chemistry, currently serving as the Director of Isotope Development at Perspective Therapeutics since May 2024. Previously, Andrew held various positions at Sandia National Laboratories from January 2017 to May 2024, including Principal Member of the Technical Staff, Senior Member of the Technical Staff, and Postdoctoral Researcher. Andrew began academic pursuits at The University of Iowa, where roles included Graduate Research Assistant and Graduate Teaching Assistant from August 2012 to December 2016, and also completed a Graduate Student Fellowship at Argonne National Laboratory from August 2015 to August 2016. Early career experience includes research assistance at Luther College and a software intern position at PTC. Andrew obtained a Ph.D. in Chemistry from the University of Iowa in 2016 and a Bachelor of Arts in Chemistry from Luther College in 2012.